Liquid Chromatographic Method for the Simultaneous Determination of Eprosartan and Hydrochlorothiazide in Tablets and Human PlasmaBELAL, Fathalla; EL-BRASHY, Amina M; EL-ENANY, Nahed et al.Journal of AOAC International. 2011, Vol 94, Num 3, pp 823-832, issn 1060-3271, 10 p.Article

Development and Validation of a High-Performance Liquid Chromatographic Method for Determination of Eprosartan in Bulk Drug and TabletsPATEL, Harsha U; SUHAGIA, Bhanubhai N; PATEL, Chhaganbhai N et al.Journal of AOAC International. 2010, Vol 93, Num 6, pp 1862-1867, issn 1060-3271, 6 p.Article

AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gainHEUSSER, Karsten; VITKOVSKY, Jan; SCHMIEDER, Roland E et al.Autonomic neuroscience : basic & clinical. 2003, Vol 107, Num 1, pp 45-51, issn 1566-0702, 7 p.Article

Effect of eprosartan on the sympathetic response to cold pressor test in healthy volunteersISRAEL, Anita; ZAVALA, Lida E; CIERCO, Maria et al.Autonomic neuroscience : basic & clinical. 2006, Vol 126-27, pp 179-184, issn 1566-0702, 6 p.Conference Paper

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertensionGRADMAN, A. H; GRAY, J; MAGGIACOMO, F et al.Clinical therapeutics. 1999, Vol 21, Num 3, pp 442-453, issn 0149-2918Article

Efficacy and safety of eprosartan in severe hypertensionSEGA, R.Blood pressure. 1999, Vol 8, Num 2, pp 114-121, issn 0803-7051Article

Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertensionLABIOS, Manuel; MART'NEZ, Marcial; GABRIEL, Francisco et al.American journal of hypertension. 2004, Vol 17, Num 9, pp 757-763, issn 0895-7061, 7 p.Article

Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertensionLEVINE, Barton.Current medical research and opinion. 2001, Vol 17, Num 1, pp 8-17, issn 0300-7995Article

Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertensionPUIG, J. G; MATEOS, F; BUNO, A et al.Journal of hypertension. 1999, Vol 17, Num 7, pp 1033-1039, issn 0263-6352Article

Haemodynamic effects of eprosartan and valsartan in hypertensive patients during isometric and mental stressAROSIO, Enrico; DE MARCHI, Sergio; PRIOR, Manlio et al.Journal of hypertension. 2005, Vol 23, Num 10, pp 1923-1927, issn 0263-6352, 5 p.Article

Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertensionWHITE, William B; YUSRA ANIS ANWAR; MANSOOR, George A et al.American journal of hypertension. 2001, Vol 14, Num 12, pp 1248-1255, issn 0895-7061Article

Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal diseaseKOVACS, S. J; TENERO, D. M; MARTIN, D. E et al.Pharmacotherapy. 1999, Vol 19, Num 5, pp 612-619, issn 0277-0008Article

Determination of SK&F 108566 (Teveten®) in human plasma by reversed-phase high-performance liquid chromatographyLUNDBERG, D. E; PERSON, C. R; KNOX, S et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 707, Num 1-2, pp 328-333, issn 1387-2273Article

Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failureBRODSKY, S; GURBANOV, K; ABASSI, Z et al.Hypertension (Dallas, Tex. 1979). 1998, Vol 32, Num 4, pp 746-752, issn 0194-911XArticle

Effect of age and gender on the pharmacokinetics of eprosartanTENERO, D. M; MARTIN, D. E; MILLER, A. K et al.British journal of clinical pharmacology. 1998, Vol 46, Num 3, pp 267-270, issn 0306-5251Conference Paper

Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patientsROBLES, N. R; MARTIN-AGUEDA, B; LOPEZ-MUNOZ, F et al.International journal of clinical practice (Esher). 2005, Vol 59, Num 4, pp 478-484, issn 1368-5031, 7 p.Article

Safety and tolerability of eprosartan in combination with hydrochlorothiazideBÖHM, Michael; SACHSE, Alisia.Drug safety. 2002, Vol 25, Num 8, pp 599-611, issn 0114-5916Article

Review of Eprosartan: A New Angiotensin II Receptor AntagonistHOLLENBERG, Norman K; SICA, Domenic A.Pharmacotherapy. 1999, Vol 19, Num 4, issn 0277-0008, 41 p., 2Serial Issue

Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteersKAZIERAD, D. J; MARTIN, D. E; BLUM, R. A et al.Clinical pharmacology and therapeutics. 1997, Vol 62, Num 4, pp 417-425, issn 0009-9236Article

Pharmacology of AT₁-receptor blockersUNGER, Thomas.Blood pressure. 2001, Vol 10, pp 5-10, issn 0803-7051, SUP3Conference Paper

Dehydration behavior of Eprosartan mesylate dihydrateJIE SHENG; VENKATESH, G. M; DUDDU, S. P et al.Journal of pharmaceutical sciences. 1999, Vol 88, Num 10, pp 1021-1029, issn 0022-3549Article

The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertensionHEDNER, T; HIMMELMANN, A.Journal of hypertension. 1999, Vol 17, Num 1, pp 129-136, issn 0263-6352Article

Effect of Eprosartan and Enalapril in the treatment of black hypertensive patients : Subgroup analysis of a 26-week, double-blind, multicentre studyLEVINE, B.Current medical research and opinion. 1999, Vol 15, Num 1, pp 25-32, issn 0300-7995Article

Effect of hepatic disease on the pharmacokinetics and plasma protein binding of eprosartanTENERO, D; MARTIN, D; CHAPELSKY, M et al.Pharmacotherapy. 1998, Vol 18, Num 1, pp 42-50, issn 0277-0008Article

Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin ii antagonist, in healthy male volunteersTENERO, D. M; MARTIN, D. E; ILSON, B. E et al.The Annals of pharmacotherapy. 1998, Vol 32, Num 3, pp 304-308, issn 1060-0280Article